HealthCare Global Enterprises Limited announced that its board of directors has approved a significant rights issue during their meeting held on February 17, 2026. The healthcare company's board unanimously approved the issuance of fully paid-up equity shares worth up to ₹42,500 Lakhs, marking a major capital raising initiative for the organization.

Rights Issue Details

The board approved the issuance of fully paid-up equity shares with a face value of ₹10 each, targeting eligible equity shareholders as on the record date. The rights issue will be conducted in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended.

Board Meeting Proceedings

The board meeting commenced at 5:00 PM and concluded at 7:25 PM on February 17, 2026. This decision follows the company's prior intimation dated February 8, 2026, indicating that the rights issue had been under consideration by the management.

Terms and Implementation

The board has delegated authority to the Rights Issue Committee of the Board of Directors to determine the specific and detailed terms of the rights issue. Key aspects that will be finalized by the committee include:

• Issue price determination
• Rights entitlement ratio
• Record date specification
• Timing of the rights issue
• Terms of payment

These details will be disclosed to the stock exchanges in due course as they are finalized by the authorized committee.

Regulatory Compliance

The rights issue is subject to obtaining necessary regulatory and statutory approvals as required under applicable laws. The company has filed the required disclosure pursuant to Regulation 30 of SEBI Listing Regulations, along with the circular requirements specified in SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The rights issue represents a significant capital raising exercise for HealthCare Global Enterprises Limited, providing eligible shareholders with the opportunity to participate in the company's growth plans through additional equity investment.

Healthcare global enterprises has announced a crucial board meeting scheduled for February 17, 2026, to consider a significant fund raise proposal. The company has formally notified stock exchanges about the upcoming deliberations on equity fundraising through rights issue mechanism.

Board Meeting Details

The Board of Directors meeting has been scheduled in compliance with regulatory requirements under SEBI Listing Regulations. The company issued the intimation on February 08, 2026, to both major stock exchanges where its shares are listed.

Fund Raise Proposal

The primary agenda involves considering and approving a proposal for fund raising through the issuance of equity shares via rights issue. This mechanism allows existing shareholders to purchase additional shares at a predetermined price, typically below market value. The proposal remains subject to applicable laws and requisite regulatory and statutory approvals.

Trading Window Restrictions

In adherence to insider trading prevention protocols, HealthCare Global Enterprises has implemented a trading window closure for all designated persons. This measure ensures compliance with SEBI's Prohibition of Insider Trading Regulations, 2015.

Regulatory Compliance

The intimation has been issued pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally communicated with both NSE and BSE compliance departments, ensuring transparent disclosure to market participants.

The announcement reflects the company's commitment to maintaining regulatory compliance while exploring strategic funding options. Additional information regarding this development is available on the company's official website at hcgoncology.com.